APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast Sodium Granules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Montelukast Sodium Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025195 pages

Choose your research edition.

Industry ResearchMontelukast Sodium Granules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast Sodium Granules Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Montelukast Sodium Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast Sodium Granules Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast Sodium Granules Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Montelukast Sodium Granules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Montelukast Sodium Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Montelukast Sodium Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Montelukast Sodium Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Montelukast Sodium Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Montelukast Sodium Granules include Teva Pharmaceutical Industries, Organon LLC, Novartis, Hengrui Medicine, Hybio Pharmaceutical, Pfizer, Mylan Pharmaceuticals, Luye Pharma Group and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Montelukast Sodium Granules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Montelukast Sodium Granules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Montelukast Sodium Granules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Montelukast Sodium Granules market size, projected growth trends, production technologies, key applications, and end-use industries.

Montelukast Sodium Granules Segment by Company

Teva Pharmaceutical Industries

Organon LLC

Novartis

Hengrui Medicine

Hybio Pharmaceutical

Pfizer

Mylan Pharmaceuticals

Luye Pharma Group

Dr. Reddy's Laboratories

Dong-A ST

Montelukast Sodium Granules Segment by Type

5mg

10mg

Montelukast Sodium Granules Segment by Application

Hospital

Clinic

Others

Montelukast Sodium Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Montelukast Sodium Granules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Montelukast Sodium Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Montelukast Sodium Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Montelukast Sodium Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Montelukast Sodium Granules Industry Trends Table 2. Montelukast Sodium Granules Industry Drivers Table 3. Montelukast Sodium Granules Industry Opportunities and Challenges Table 4. Montelukast Sodium Granules Industry Restraints Table 5. Global Montelukast Sodium Granules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Montelukast Sodium Granules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Montelukast Sodium Granules Sales by Manufacturers (K G) & (2021-2026) Table 8. Global Montelukast Sodium Granules Sales Market Share by Manufacturers Table 9. Global Montelukast Sodium Granules Average Sales Price (US$/K G) of Manufacturers (2021-2026) Table 10. Global Montelukast Sodium Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Montelukast Sodium Granules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Montelukast Sodium Granules Manufacturers, Product Type & Application Table 13. Global Montelukast Sodium Granules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Montelukast Sodium Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5mg Table 17. Major Manufacturers of 10mg Table 18. Global Montelukast Sodium Granules Sales by Type 2021 VS 2025 VS 2032 (K G) Table 19. Global Montelukast Sodium Granules Sales by Type (2021-2026) & (K G) Table 20. Global Montelukast Sodium Granules Sales by Type (2027-2032) & (K G) Table 21. Global Montelukast Sodium Granules Sales Market Share by Type (2021-2026) Table 22. Global Montelukast Sodium Granules Sales Market Share by Type (2027-2032) Table 23. Global Montelukast Sodium Granules Revenue by Type 2021 VS 2025 VS 2032 (K G) Table 24. Global Montelukast Sodium Granules Revenue by Type (2021-2026) & (K G) Table 25. Global Montelukast Sodium Granules Revenue by Type (2027-2032) & (K G) Table 26. Global Montelukast Sodium Granules Revenue Market Share by Type (2021-2026) Table 27. Global Montelukast Sodium Granules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Montelukast Sodium Granules Sales by Application 2021 VS 2025 VS 2032 (K G) Table 32. Global Montelukast Sodium Granules Sales by Application (2021-2026) & (K G) Table 33. Global Montelukast Sodium Granules Sales by Application (2027-2032) & (K G) Table 34. Global Montelukast Sodium Granules Sales Market Share by Application (2021-2026) Table 35. Global Montelukast Sodium Granules Sales Market Share by Application (2027-2032) Table 36. Global Montelukast Sodium Granules Revenue by Application 2021 VS 2025 VS 2032 (K G) Table 37. Global Montelukast Sodium Granules Revenue by Application (2021-2026) & (K G) Table 38. Global Montelukast Sodium Granules Revenue by Application (2027-2032) & (K G) Table 39. Global Montelukast Sodium Granules Revenue Market Share by Application (2021-2026) Table 40. Global Montelukast Sodium Granules Revenue Market Share by Application (2027-2032) Table 41. Global Montelukast Sodium Granules Sales by Region: 2021 VS 2025 VS 2032 (K G) Table 42. Global Montelukast Sodium Granules Sales by Region (2021-2026) & (K G) Table 43. Global Montelukast Sodium Granules Sales Market Share by Region (2021-2026) Table 44. Global Montelukast Sodium Granules Sales Forecasted by Region (2027-2032) & (K G) Table 45. Global Montelukast Sodium Granules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Montelukast Sodium Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 47. North America Montelukast Sodium Granules Sales by Country (2021-2026) & (K G) Table 48. North America Montelukast Sodium Granules Sales by Country (2027-2032) & (K G) Table 49. Europe Montelukast Sodium Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 50. Europe Montelukast Sodium Granules Sales by Country (2021-2026) & (K G) Table 51. Europe Montelukast Sodium Granules Sales by Country (2027-2032) & (K G) Table 52. Asia Pacific Montelukast Sodium Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 53. Asia Pacific Montelukast Sodium Granules Sales by Country (2021-2026) & (K G) Table 54. Asia Pacific Montelukast Sodium Granules Sales by Country (2027-2032) & (K G) Table 55. South America, Middle East and Africa Montelukast Sodium Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K G) Table 56. South America, Middle East and Africa Montelukast Sodium Granules Sales by Country (2021-2026) & (K G) Table 57. South America, Middle East and Africa Montelukast Sodium Granules Sales by Country (2027-2032) & (K G) Table 58. Global Montelukast Sodium Granules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Montelukast Sodium Granules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Montelukast Sodium Granules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Montelukast Sodium Granules Revenue Market Share by Region (2021-2026) Table 62. Global Montelukast Sodium Granules Revenue Market Share by Region (2027-2032) Table 63. Teva Pharmaceutical Industries Company Information Table 64. Teva Pharmaceutical Industries Business Overview Table 65. Teva Pharmaceutical Industries Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Industries Montelukast Sodium Granules Product Portfolio Table 67. Teva Pharmaceutical Industries Recent Development Table 68. Organon LLC Company Information Table 69. Organon LLC Business Overview Table 70. Organon LLC Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Organon LLC Montelukast Sodium Granules Product Portfolio Table 72. Organon LLC Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Novartis Montelukast Sodium Granules Product Portfolio Table 77. Novartis Recent Development Table 78. Hengrui Medicine Company Information Table 79. Hengrui Medicine Business Overview Table 80. Hengrui Medicine Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hengrui Medicine Montelukast Sodium Granules Product Portfolio Table 82. Hengrui Medicine Recent Development Table 83. Hybio Pharmaceutical Company Information Table 84. Hybio Pharmaceutical Business Overview Table 85. Hybio Pharmaceutical Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hybio Pharmaceutical Montelukast Sodium Granules Product Portfolio Table 87. Hybio Pharmaceutical Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pfizer Montelukast Sodium Granules Product Portfolio Table 92. Pfizer Recent Development Table 93. Mylan Pharmaceuticals Company Information Table 94. Mylan Pharmaceuticals Business Overview Table 95. Mylan Pharmaceuticals Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Mylan Pharmaceuticals Montelukast Sodium Granules Product Portfolio Table 97. Mylan Pharmaceuticals Recent Development Table 98. Luye Pharma Group Company Information Table 99. Luye Pharma Group Business Overview Table 100. Luye Pharma Group Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Luye Pharma Group Montelukast Sodium Granules Product Portfolio Table 102. Luye Pharma Group Recent Development Table 103. Dr. Reddy's Laboratories Company Information Table 104. Dr. Reddy's Laboratories Business Overview Table 105. Dr. Reddy's Laboratories Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Dr. Reddy's Laboratories Montelukast Sodium Granules Product Portfolio Table 107. Dr. Reddy's Laboratories Recent Development Table 108. Dong-A ST Company Information Table 109. Dong-A ST Business Overview Table 110. Dong-A ST Montelukast Sodium Granules Sales (K G), Price (US$/K G), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Dong-A ST Montelukast Sodium Granules Product Portfolio Table 112. Dong-A ST Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Montelukast Sodium Granules Distributors List Table 116. Montelukast Sodium Granules Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Montelukast Sodium Granules Product Image Figure 2. Global Montelukast Sodium Granules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast Sodium Granules Market Size (2021-2032) & (US$ Million) Figure 4. Global Montelukast Sodium Granules Sales (2021-2032) & (K G) Figure 5. Global Montelukast Sodium Granules Average Price (US$/K G) & (2021-2032) Figure 6. Global Top 5 and 10 Montelukast Sodium Granules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5mg Image Figure 9. 10mg Image Figure 10. Global Montelukast Sodium Granules Sales by Type (2021 VS 2025 VS 2032) & (K G) Figure 11. Global Montelukast Sodium Granules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Montelukast Sodium Granules Sales Market Share by Type (2021-2032) Figure 13. Global Montelukast Sodium Granules Revenue by Type (2021 VS 2025 VS 2032) & (K G) Figure 14. Global Montelukast Sodium Granules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Montelukast Sodium Granules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Montelukast Sodium Granules Sales by Application (2021 VS 2025 VS 2032) & (K G) Figure 20. Global Montelukast Sodium Granules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Montelukast Sodium Granules Sales Market Share by Application (2021-2032) Figure 22. Global Montelukast Sodium Granules Revenue by Application (2021 VS 2025 VS 2032) & (K G) Figure 23. Global Montelukast Sodium Granules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Montelukast Sodium Granules Revenue Market Share by Application (2021-2032) Figure 25. North America Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 26. North America Montelukast Sodium Granules Sales Market Share by Country (2021-2032) Figure 27. U.S. Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 28. Canada Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 29. Mexico Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 30. Europe Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 31. Europe Montelukast Sodium Granules Sales Market Share by Country (2021-2032) Figure 32. Germany Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 33. France Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 34. U.K. Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 35. Italy Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 36. Netherlands Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 37. Asia Pacific Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 38. Asia Pacific Montelukast Sodium Granules Sales Market Share by Country (2021-2032) Figure 39. China Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 40. Japan Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 41. South Korea Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 42. Southeast Asia Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 43. India Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 44. Australia Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 45. South America, Middle East and Africa Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 46. South America, Middle East and Africa Montelukast Sodium Granules Sales Market Share by Country (2021-2032) Figure 47. Brazil Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 48. South Africa Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 49. Saudi Arabia Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 50. Turkey Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 51. Argentina Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 52. UAE Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 53. Egypt Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 54. Chile Montelukast Sodium Granules Sales and Growth Rate (2021-2032) & (K G) Figure 55. Global Montelukast Sodium Granules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Montelukast Sodium Granules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Montelukast Sodium Granules Revenue (2021-2032) & (US$ Million) Figure 58. North America Montelukast Sodium Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Montelukast Sodium Granules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Montelukast Sodium Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Montelukast Sodium Granules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Montelukast Sodium Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Montelukast Sodium Granules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Montelukast Sodium Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Montelukast Sodium Granules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Montelukast Sodium Granules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Organon LLC
  • Novartis
  • Hengrui Medicine
  • Hybio Pharmaceutical
  • Pfizer
  • Mylan Pharmaceuticals
  • Luye Pharma Group
  • Dr. Reddy's Laboratories
  • Dong-A ST

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Montelukast Sodium Granules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Montelukast Sodium Granules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Montelukast Sodium Granules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Montelukast Sodium Granules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Montelukast Sodium Granules Market Dynamics
  1. 2.1 Montelukast Sodium Granules Industry Trends
  2. 2.2 Montelukast Sodium Granules Industry Drivers
  3. 2.3 Montelukast Sodium Granules Industry Opportunities and Challenges
  4. 2.4 Montelukast Sodium Granules Industry Restraints
3 Montelukast Sodium Granules Market by Manufacturers
  1. 3.1 Global Montelukast Sodium Granules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Montelukast Sodium Granules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Montelukast Sodium Granules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Montelukast Sodium Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Montelukast Sodium Granules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Montelukast Sodium Granules Manufacturers, Product Type & Application
  7. 3.7 Global Montelukast Sodium Granules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Montelukast Sodium Granules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Montelukast Sodium Granules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Montelukast Sodium Granules Tier 1, Tier 2, and Tier 3
4 Montelukast Sodium Granules Market by Type
  1. 4.1 Montelukast Sodium Granules Type Introduction
  2. 4.1.1 5mg
  3. 4.1.2 10mg
  4. 4.2 Global Montelukast Sodium Granules Sales by Type
  5. 4.2.1 Global Montelukast Sodium Granules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Montelukast Sodium Granules Sales by Type (2021-2032)
  7. 4.2.3 Global Montelukast Sodium Granules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Montelukast Sodium Granules Revenue by Type
  9. 4.3.1 Global Montelukast Sodium Granules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Montelukast Sodium Granules Revenue by Type (2021-2032)
  11. 4.3.3 Global Montelukast Sodium Granules Revenue Market Share by Type (2021-2032)
5 Montelukast Sodium Granules Market by Application
  1. 5.1 Montelukast Sodium Granules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Montelukast Sodium Granules Sales by Application
  6. 5.2.1 Global Montelukast Sodium Granules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Montelukast Sodium Granules Sales by Application (2021-2032)
  8. 5.2.3 Global Montelukast Sodium Granules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Montelukast Sodium Granules Revenue by Application
  10. 5.3.1 Global Montelukast Sodium Granules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Montelukast Sodium Granules Revenue by Application (2021-2032)
  12. 5.3.3 Global Montelukast Sodium Granules Revenue Market Share by Application (2021-2032)
6 Global Montelukast Sodium Granules Sales by Region
  1. 6.1 Global Montelukast Sodium Granules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Montelukast Sodium Granules Sales by Region (2021-2032)
  3. 6.2.1 Global Montelukast Sodium Granules Sales by Region (2021-2026)
  4. 6.2.2 Global Montelukast Sodium Granules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Montelukast Sodium Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Montelukast Sodium Granules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Montelukast Sodium Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Montelukast Sodium Granules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Montelukast Sodium Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Montelukast Sodium Granules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Montelukast Sodium Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Montelukast Sodium Granules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Montelukast Sodium Granules Revenue by Region
  1. 7.1 Global Montelukast Sodium Granules Revenue by Region
  2. 7.1.1 Global Montelukast Sodium Granules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Montelukast Sodium Granules Revenue by Region (2021-2026)
  4. 7.1.3 Global Montelukast Sodium Granules Revenue by Region (2027-2032)
  5. 7.1.4 Global Montelukast Sodium Granules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Montelukast Sodium Granules Revenue (2021-2032)
  8. 7.2.2 North America Montelukast Sodium Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Montelukast Sodium Granules Revenue (2021-2032)
  11. 7.3.2 Europe Montelukast Sodium Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Montelukast Sodium Granules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Montelukast Sodium Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Montelukast Sodium Granules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Montelukast Sodium Granules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Montelukast Sodium Granules Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Organon LLC
  8. 8.2.1 Organon LLC Company Information
  9. 8.2.2 Organon LLC Business Overview
  10. 8.2.3 Organon LLC Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Organon LLC Montelukast Sodium Granules Product Portfolio
  12. 8.2.5 Organon LLC Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Montelukast Sodium Granules Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Hengrui Medicine
  20. 8.4.1 Hengrui Medicine Company Information
  21. 8.4.2 Hengrui Medicine Business Overview
  22. 8.4.3 Hengrui Medicine Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hengrui Medicine Montelukast Sodium Granules Product Portfolio
  24. 8.4.5 Hengrui Medicine Recent Developments
  25. 8.5 Hybio Pharmaceutical
  26. 8.5.1 Hybio Pharmaceutical Company Information
  27. 8.5.2 Hybio Pharmaceutical Business Overview
  28. 8.5.3 Hybio Pharmaceutical Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hybio Pharmaceutical Montelukast Sodium Granules Product Portfolio
  30. 8.5.5 Hybio Pharmaceutical Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Montelukast Sodium Granules Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Mylan Pharmaceuticals
  38. 8.7.1 Mylan Pharmaceuticals Company Information
  39. 8.7.2 Mylan Pharmaceuticals Business Overview
  40. 8.7.3 Mylan Pharmaceuticals Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Pharmaceuticals Montelukast Sodium Granules Product Portfolio
  42. 8.7.5 Mylan Pharmaceuticals Recent Developments
  43. 8.8 Luye Pharma Group
  44. 8.8.1 Luye Pharma Group Company Information
  45. 8.8.2 Luye Pharma Group Business Overview
  46. 8.8.3 Luye Pharma Group Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Luye Pharma Group Montelukast Sodium Granules Product Portfolio
  48. 8.8.5 Luye Pharma Group Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Montelukast Sodium Granules Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Dong-A ST
  56. 8.10.1 Dong-A ST Company Information
  57. 8.10.2 Dong-A ST Business Overview
  58. 8.10.3 Dong-A ST Montelukast Sodium Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dong-A ST Montelukast Sodium Granules Product Portfolio
  60. 8.10.5 Dong-A ST Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Montelukast Sodium Granules Value Chain Analysis
  2. 9.1.1 Montelukast Sodium Granules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Montelukast Sodium Granules Production Mode & Process
  6. 9.2 Montelukast Sodium Granules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Montelukast Sodium Granules Distributors
  9. 9.2.3 Montelukast Sodium Granules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst